Severe Hyponatremia with Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials. Open Access Indonesian Journal of Medical Reviews, v. 6, n. 1, p. 35–50, 27 Nov.2025.